Dr. Frank Douglas Part of TEDMED Panel Exploring Cancer-Free World

On Tuesday, April 16, Dr. Frank L. Douglas, Austen BioInnovation Institute President and CEO, will participate in the TEDMED Conference during a special discussion on “The Value of Medical Innovation: A World Free from Cancer” at the John F. Kennedy Center for Performing Arts in Washington, D.C.  Scientific American is conducting the forum, in collaboration with Celgene and TEDMED, a multi-disciplinary community of innovators and leaders who are determined to create a better future in health and medicine.

The panel discussion, being moderated by journalist and NPR host David Brancaccio, includes Dr. Douglas; Dr. Lou Degennaro, Executive Vice President and Chief Mission Officer of the Leukemia & Lymphoma Society; Dr. Tomas Philipson, Daniel Levin Professor of Public Policy Studies in the Irving B. Harris Graduate School of Public Policy Studies at The University of Chicago; and Dr. Bob Hariri, Celgene Cellular Therapeutics CEO.

The event will allow engagement through a two-way dialogue, examining opportunities and challenges, through the eyes of the experts, on ways we can work together in the mission for a cancer-free world.  For more information on the TEDMED Conference, please visit their website at www.tedmed.com.